Can a blood test help diagnose skin cancer?

Published On 2022-05-04 03:30 GMT | Update On 2022-05-04 03:30 GMT

New research in Advanced NanoBiomed Research indicates that testing an individual's blood can reveal the presence of circulating melanoma cells. Such tests may allow patients to forego invasive skin biopsies to determine whether they have skin cancer.

The test uses what's called the Melanoma-specific OncoBean platform conjugated with melanoma-specific antibodies. Investigators at the University of Michigan showed that the test can be used not only to diagnose melanoma but also to evaluate whether all cancer cells have been successfully removed after skin cancer surgery.

"This is the first comprehensive study of circulating tumor cells—or CTCs—to evaluate the efficacy of surgery using microfluidic systems in melanoma, including changes in the number of CTCs, CTC cluster configuration, and gene expression profiling," said first author, Yoon-Tae Kang, PhD. "CTCs have the potential to pinpoint treatment resistance and recurrence, and can be a valuable biomarker to non-invasively monitor for disease progression," added corresponding author Sunitha Nagrath, PhD.

DOI

10.1002/anbr.202100083

Article Source : Advanced NanoBiomed Research

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Can a blood test help diagnose skin cancer?

Similar News

Biologic Therapy may Lower Malignancy Risk in Psoriasis,suggests study

Maternal Dietary Diversity Lowers Childhood Eczema Risk: Study

AOPT-LTL Therapy Improves Melasma via SCF/c-KIT Pathway Inhibition: Study Finds

Psoriatic Arthritis Patients Face Higher Burden of Metabolic Syndrome, Meta-Analysis Shows

Oral vs. Topical TXA: Comparable Effectiveness and Safety in treatment of Melasma

Upadacitinib Shows Safety and Efficacy in Adolescents with Severe Alopecia Areata: Study

Melanoma Patients Face Greater Risk of Vitiligo, Psoriasis, and Other Autoimmune Conditions: Study Finds

Methotrexate and TNF Inhibitors Linked to Lowest Cardiovascular Risk in Psoriasis: Study